Usana Health Sciences (USNA) Market Capitalization (2010 - 2026)

Usana Health Sciences (USNA) has reported Market Capitalization for 17 consecutive years, with $397.1 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Market Capitalization fell 30.14% year-over-year to $397.1 million in Q3 2026; TTM through Jul 2026 was $397.1 million, a 30.14% decrease from a year earlier, with the FY2026 full-year figure at $355.4 million, down 47.77% from the prior year.
• Market Capitalization was $397.1 million for Q3 2026 at Usana Health Sciences, up from $311.9 million in the prior quarter.
• Over five years, Market Capitalization peaked at $2.0 billion in Q1 2022 and troughed at $311.9 million in Q2 2026.
• A 5-year average of $919.1 million and a median of $923.8 million in 2024 frame the typical range for Market Capitalization.
• The widest YoY moves for Market Capitalization: up 20.99% in 2022, down 47.94% in 2022.
• Over 5 years, Market Capitalization stood at $1.0 billion in 2022, then gained by 0.35% to $1.0 billion in 2023, then sank by 33.64% to $680.4 million in 2024, then dropped by 23.38% to $521.3 million in 2025, then retreated by 23.82% to $397.1 million in 2026.
• The last three Market Capitalization figures came in at $397.1 million (Q3 2026), $311.9 million (Q2 2026), and $355.4 million (Q1 2026), per Business Quant data.